Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Rheumatology _ Arthritis, Fibromyalgia
Dogwood Therapeutics, Inc. (NASDAQ: DWTX), formerly, Virios Therapeutics, Inc. (NASDAQ: VIRI)*

Organization & Developments: Virios Therapeutics

Parents

Dogwood Therapeutics, Inc. (NASDAQ: DWTX), formerly, Virios Therapeutics, Inc. (NASDAQ: VIRI)*

2020: Atlanta biotech company Virios Therapeutics files for $34M IPO
Virios Therapeutics is a clinical-stage biopharmaceutical company developing and commercializing innovative antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM)
Virios Therapeutics, Inc. (Nasdaq: VIRI) is a biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia.